Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
1.
Pol Merkur Lekarski ; 1(3): 174-8, 1996 Sep.
Artículo en Polaco | MEDLINE | ID: mdl-9139781

RESUMEN

In the present study, the effectiveness of a triple therapy for eradication of Helicobacter pylori was evaluated. Therapy consisted of 120 mg tripotassium dicitrato bismuthate q.d.s. for four weeks, 500 mg amoxycillin q.d.s. and 500 mg metronidazole t.d.s. for two weeks. In 77 Helicobacter pylori-positive patients with duodenal ulcers (n = 32), gastritis (n = 18) and after gastric resection (n = 7), rapid urease-based test, culture, histology and serology were used to confirm the eradication, or relapse. The overall eradication rate was 75.3%, ulcers were healed in 82.1% and an improvement of the endoscopic gastritis was observed in 75.3% of the patients. The eradication rates were not statistically different among the subgroups. 1-3 months after the treatment IgG titres had fallen by 25% and over in 67.5% of the patients irrespective of the success of bacterial eradication. Side effects, particularly diarrhoea and nausea, were common (53.2%) but mild. Only 6.5% of the patients' had to discontinue the treatment because side effects became intolerable.


Asunto(s)
Antibacterianos/uso terapéutico , Gastritis/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/aislamiento & purificación , Compuestos Organometálicos/administración & dosificación , Úlcera Gástrica/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Amoxicilina/administración & dosificación , Esquema de Medicación , Quimioterapia Combinada , Femenino , Gastritis/cirugía , Infecciones por Helicobacter/cirugía , Humanos , Masculino , Metronidazol/administración & dosificación , Persona de Mediana Edad , Úlcera Gástrica/cirugía , Resultado del Tratamiento
2.
Pol Merkur Lekarski ; 1(5): 355-8, 1996 Nov.
Artículo en Polaco | MEDLINE | ID: mdl-9273218

RESUMEN

Recent developments in the field of new, non-invasive, sensitive methods of cancer detection based on measurements of autofluorescence of cells are discussed. Research oriented on a detection of human cancer has been carried on by several groups for last six years only but has already yielded important data pointing to a possibility of both in situ and in vitro detection of cancerous tissues in several human organs, especially lung, gynecological tract, skin and gastro-intestinal tract. At least two such methods have been currently subject to clinical tests.


Asunto(s)
Neoplasias/diagnóstico , Espectrometría de Fluorescencia/métodos , Humanos , Óptica y Fotónica , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA